It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. After-hours trades for Dynavax Technologies Corp. (DVAX) shows that investor sentiment remained intact, with the stock’s consolidated last price rising by $0.25, or 1.85%, to $13.78. The Dynavax Technologies Corp. has recorded 71,358 volume in the after hours trading session. Earlier, Yahoo Finance discussed this stock as it revealed Dynavax Reports Third Quarter 2023 Financial Results and Raises Full Year Revenue Guidance.
Dynavax Technologies Corp. is listed on the NASDAQ in the Healthcare sector while operating in the Drug Manufacturers – Specialty & Generic industry. The current market capitalization of Dynavax Technologies Corp. is $1.75B. A total of 1.65 million shares were traded on the day, compared to an average of 1.52M shares.
Insider trades are also considered as indicators of how a stock will perform in the future, in addition to stock predictions. During the recent three months, DVAX has seen 5 BUY and 6 SELL insider trades, representing the acquisition of 100,472 and the disposition of 100,472 shares. Over the last 12 months, there were 35 BUYs and 33 SELLs from insiders. Insiders purchased 337,256 shares during that period but sold 4,748,719.
In the most recent transaction, Novack David F sold 20,000 shares of DVAX for 15.00 per share on Nov 03. After the transaction, the President & COO now owns 3,187 company shares. In a previous transaction on Nov 01, Novack David F sold 20,000 shares at 14.12 per share. DVAX shares that President & COO owns now total 3,187.
Among the insiders who sold shares, Janssen Robert disposed of 1,755 shares on Oct 10 at a per-share price of $15.01. This resulted in the SVP and CMO holding 49,925 shares of DVAX after the transaction. In another insider transaction, Novack David F sold 40,000 shares at $14.88 per share on Oct 02. Company shares held by the President & COO now total 3,187.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. According to analysts who have offered 12-month price targets for DVAX in the last 3 months, the mean price target is $25.00 with high estimates of $28.00 and low estimates of $21.00. In terms of 52-week highs and lows, DVAX has a high of $15.15 and a low of $9.42.
As of this writing, DVAX has an earnings estimate of $0 per share for the current quarter. EPS was calculated based on a consensus of 4 estimates, with a high estimate of $0.03 per share and a lower estimate of -$0.03. The company reported an EPS of $0.03 in the last quarter, which was 133.30% higher than expectations of -$0.09.
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. DVAX’s latest balance sheet shows that the firm has $545.95M in Cash & Short Term Investments as of fiscal 2021. There were $257.38M in debt and $556.40M in liabilities at the time. Its Book Value Per Share was $4.68, while its Total Shareholder’s Equity was $222.37M.
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for DVAX is Buy with a score of 5.00.